Recent progresses in marine microbial-derived antiviral natural products

Arch Pharm Res. 2020 Dec;43(12):1215-1229. doi: 10.1007/s12272-020-01286-3. Epub 2020 Nov 21.

Abstract

Viruses have always been a class of pathogenic microorganisms that threaten the health and safety of human life worldwide. However, for a long time, the treatment of viral infections has been slow to develop, and only a few antiviral drugs have been using clinically. Compared with these from terrestrial environments, marine-derived microorganisms can produce active substances with more novel structures and unique functions. From 2015 to 2019, 89 antiviral compounds of 8 structural classes have been isolated from marine microorganisms, of which 35 exhibit anti-H1N1 activity. This review surveys systematically marine microbial-derived natural products with antiviral activity and illustrates the impact of these compounds on antiviral drug discovery research.

Keywords: Antiviral activity; Marine microorganism; Marine natural products; Structure–activity relationships.

Publication types

  • Review

MeSH terms

  • Animals
  • Antiviral Agents / isolation & purification
  • Antiviral Agents / pharmacology*
  • Aquatic Organisms / metabolism*
  • Drug Discovery*
  • Host-Pathogen Interactions
  • Humans
  • Influenza A Virus, H1N1 Subtype / drug effects
  • Influenza A Virus, H1N1 Subtype / pathogenicity
  • Influenza, Human / drug therapy
  • Influenza, Human / virology
  • Molecular Structure
  • Structure-Activity Relationship
  • Virus Diseases / drug therapy*
  • Virus Diseases / virology
  • Viruses / drug effects*
  • Viruses / pathogenicity

Substances

  • Antiviral Agents